Attana AB (NGM:ATANA) EBITDA Margin %: -177.03% (As of Mar. 2026)


What is Attana AB EBITDA Margin %?

Attana AB NGM:ATANA EBITDA Margin % is -177.03% as of Mar. 2026. The stock has 4 warning signs investors should review. Among 203 Medical Diagnostics & Research companies, Attana AB ranks worse than 91.13% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Attana AB's EBITDA for the three months ended in Mar. 2026 was kr-0.76 Mil. Attana AB's Revenue for the three months ended in Mar. 2026 was kr0.43 Mil. Therefore, Attana AB's EBITDA margin for the quarter that ended in Mar. 2026 was -177.03%.

Attana AB  (NGM:ATANA) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Attana AB EBITDA Margin % Related Terms

Attana AB EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Attana AB's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attana AB EBITDA Margin % Chart

Attana AB Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only -875.95 -152.07 -200.87 -114.47 -338.86

Attana AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.01 -864.40 -1,883.46 -762.78 -177.03

NGM:ATANA vs TMO, DHR, IDXX: EBITDA Margin % Comparison

For the Diagnostics & Research subindustry, Attana AB's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Attana AB EBITDA Margin % vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Attana AB's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Attana AB's EBITDA Margin % falls into.


Attana AB EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Attana AB's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-8.38/2.473
=-338.86 %

Attana AB's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-0.763/0.431
=-177.03 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -177.03% mean?
Attana AB (NGM:ATANA) has a EBITDA Margin % of -177.03% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Attana AB and its competitors. According to the industry distribution chart, Attana AB ranks #185 out of 203 companies in the Medical Diagnostics & Research industry, placing it in the top 91.1%.
Is Attana AB's EBITDA Margin % too high?
Attana AB's current EBITDA Margin % is -177.03%. Based on the distribution chart, Attana AB ranks #185 out of 203 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Attana AB's EBITDA Margin % compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Attana AB ranks #185 out of 203 companies for EBITDA Margin %. This places Attana AB in the lower half of its industry. The industry median EBITDA Margin % is 5.00. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Diagnostics & Research company?
The median EBITDA Margin % among Medical Diagnostics & Research companies is 5.00, based on 203 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Attana AB and its competitors. For the Medical Diagnostics & Research industry, the median EBITDA Margin % is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Attana AB's current EBITDA Margin % is -177.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attana AB stock overvalued right now?
Attana AB (NGM:ATANA) has a current EBITDA Margin % of -177.03%. The current EBITDA Margin % is -177.03%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Attana AB (NGM:ATANA), the current EBITDA Margin % is -177.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Attana AB Business Description

Address Bjornnasvagen 21, Stockholm, SWE, SE-114 19
Attana AB offers biologically relevant information to improve efficiency and performance of pharmaceutical drug development.